CEL-SCI CORP: Director Changes & Officer Compensation Updates
Ticker: CVM · Form: 8-K · Filed: Nov 15, 2024 · CIK: 725363
Sentiment: neutral
Topics: director-change, executive-compensation
Related Tickers: CVM
TL;DR
CEL-SCI CORP board shakeup and pay adjustments announced.
AI Summary
CEL-SCI CORPORATION announced on November 13, 2024, changes related to its board of directors and executive compensation. Specifically, the company reported the departure of a director, the election of a new director, and adjustments to compensatory arrangements for certain officers. The filing details these changes as required by SEC regulations.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directorship and executive compensation can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- CEL-SCI CORPORATION (company) — Registrant
- November 13, 2024 (date) — Earliest event reported
- Colorado (jurisdiction) — State of incorporation
- 8229 Boone Blvd. #802 Vienna, VA 22182 (address) — Principal executive offices
- 703 (phone_number) — Registrant's telephone number area code
FAQ
What specific changes were made regarding the board of directors?
The filing indicates the departure of a director and the election of a new director.
What other key information is reported in this 8-K filing?
The filing also reports on compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported was on November 13, 2024.
What is CEL-SCI CORPORATION's state of incorporation?
CEL-SCI CORPORATION is incorporated in Colorado.
What is the principal executive office address for CEL-SCI CORPORATION?
The principal executive office is located at 8229 Boone Blvd. #802 Vienna, VA 22182.
Filing Stats: 416 words · 2 min read · ~1 pages · Grade level 11.7 · Accepted 2024-11-15 16:30:54
Filing Documents
- cvm_8k.htm (8-K) — 20KB
- 0001654954-24-014554.txt ( ) — 140KB
- cvm-20241113.xsd (EX-101.SCH) — 6KB
- cvm-20241113_lab.xml (EX-101.LAB) — 14KB
- cvm-20241113_cal.xml (EX-101.CAL) — 1KB
- cvm-20241113_pre.xml (EX-101.PRE) — 9KB
- cvm-20241113_def.xml (EX-101.DEF) — 2KB
- cvm_8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 15, 2024 CEL-SCI CORPORATION By: /s/Geert R. Kersten Geert R. Kersten, Chief Executive Officer 3